Approvals Up, Revenues Down, But R&D Productivity on Mend
By Nuala Moran
Thursday, December 6, 2012
LONDON – The good news is that the number of product approvals granted to the top 12 pharma companies increased by one-third in 2012.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.